Abstract: Parathyroid carcinoma only represents <1% of all cases of primary hyperparathyroidism (PHPT). Even rare, chronic PHPT may lead to excessive osteoclast activity, and the increased resorption leads to destruction of cortical bone and formation of fibrous cysts with deposits of hemosiderin-so-called brown tumors. These benign, osteolytic lesions may demonstrate FDG-avidity on 18 F-FDG PET/CT, and as such are misinterpreted as skeletal metastases. Regression of the lesions may occur following successful treatment. We present a case demonstrating the diagnostic work-up and follow-up of a patient with PHPT due to parathyroid carcinoma and with presence of brown tumors on 18 F-FDG PET/CT, visualizing the possible role of this imaging modality in the evaluation of treatment response in these patients.
F-FDG PET/CT scan was performed 3 months after surgery, and the previously seen osteolytic lesions were sclerotized with normal or only slightly increased FDG uptake. SUVmax of the previously mentioned costal lesion on the right side was now 2.5 (white arrows). In addition, both the patient's symptoms as well as plasma levels of PTH and ionized calcium were normalized on further medical treatment. The lesions initially seen on 18 F-FDG PET/CT were concluded as being benign brown tumors due to PHPT in this patient with parathyroid carcinoma. This case illustrates two clinical dilemmas: (1) A patient with parathyroid carcinoma, which was not visible on 18 F-FDG PET due to lack of pathological FDG uptake in the tumor detected on CT; (2) The presence of multiple benign bone lesions with high FDG-avidity, which mimicked metastatic disease and as such could be misinterpreted. Parathyroid carcinoma is rare, representing <1% of all cases of PHPT [1] . Even though 18 F-FDG PET/CT can offer information regarding lesion metabolism and potential loco-regional and/or distant spread of malignant disease [2] , it probably has no place in the diagnostic work-up in a group of unselected patients with PHPT [3] . Despite the nomenclature, brown tumors are not true neoplasms, but rare, benign osteolytic lesions, which arise in the setting of excessive osteoclast activity in patients with hyperparathyroidism. The increased resorption leads to destruction of cortical bone and formation of fibrous cysts. Microscopically, hemosiderin deposition in the cysts gives a characteristic brown coloration and osteoclast-like giant cells may be present. The increased FDG uptake, which can be seen in these lesions (possibly due to the presence of osteoclast-like giant cells and macrophage glucose metabolism [4] ), may mimic skeletal metastasis on 18 F-FDG PET/CT. However, regression of the lesions has been reported after successful parathyroidectomy [5] [6] [7] , supported by the findings in our case report. This indicates a possible role of 18 F-FDG PET/CT in the evaluation of treatment response in these patients.
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